| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Department of Physiology, National University of Singapore, Singapore
The aim of our study was to investigate the roles played by sphingosine kinase (SPHK) in the anaphylatoxin C5a-triggered responses in vivo. Our data show that i.v. administration of C5a triggers a rapid neutropenic response, but pretreating mice with the SPHK inhibitor, N,N-dimethylsphingosine (DMS), 10 min before the C5a i.v. administration substantially inhibited the C5a-triggered neutropenia. Similarly the i.v. administration of C5a caused a rapid increase in the serum levels of TNF-
and IL-6, and this increase in cytokine levels was blocked by DMS. We then induced acute peritonitis with C5a. The C5a i.p. injection triggered a fast recruitment of neutrophils, later followed by monocytes, into the peritoneal cavity. Vascular permeability was also observed: when we i.v. injected Evans blue before C5a i.p. injection, we could observe a continued influx of the dye into the peritoneum. In mice pretreated with DMS, there was a significant reduction on the C5a-triggered neutrophil and monocyte infiltration, as well as a marked reduction on the Evans blue influx. Our data also show that the i.p. administration of C5a caused a rapid increase in TNF- and IL-6 levels in the peritoneal cavity, and this increase in cytokine levels was substantially inhibited in mice pretreated with the SPHK inhibitor. Taken together, these observations suggest a potential role for SPHK in the C5a-triggered inflammatory responses in vivo.
This article has been cited by other articles:
|
|
 |
|
  P. N. Pushparaj, H. K. Tay, C.-C. Wang, W. Hong, and A. J. Melendez VAMP8 Is Essential in Anaphylatoxin-Induced Degranulation, TNF-{alpha} Secretion, Peritonitis, and Systemic Inflammation J. Immunol., July 15, 2009; 183(2): 1413 - 1418. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Wadgaonkar, V. Patel, N. Grinkina, C. Romano, J. Liu, Y. Zhao, S. Sammani, J. G. N. Garcia, and V. Natarajan Differential regulation of sphingosine kinases 1 and 2 in lung injury Am J Physiol Lung Cell Mol Physiol, April 1, 2009; 296(4): L603 - L613. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. J. Snider, T. Kawamori, S. G. Bradshaw, K. A. Orr, G. S. Gilkeson, Y. A. Hannun, and L. M. Obeid A role for sphingosine kinase 1 in dextran sulfate sodium-induced colitis FASEB J, January 1, 2009; 23(1): 143 - 152. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W.-Q. Lai, A. W. Irwan, H. H. Goh, H. S. Howe, D. T. Yu, R. Valle-Onate, I. B. McInnes, A. J. Melendez, and B. P. Leung Anti-Inflammatory Effects of Sphingosine Kinase Modulation in Inflammatory Arthritis J. Immunol., December 1, 2008; 181(11): 8010 - 8017. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Tauseef, V. Kini, N. Knezevic, M. Brannan, R. Ramchandaran, H. Fyrst, J. Saba, S. M. Vogel, A. B. Malik, and D. Mehta Activation of Sphingosine Kinase-1 Reverses the Increase in Lung Vascular Permeability Through Sphingosine-1-Phosphate Receptor Signaling in Endothelial Cells Circ. Res., November 7, 2008; 103(10): 1164 - 1172. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P.N. Pushparaj, J.J. Aarthi, J. Manikandan, and S.D. Kumar siRNA, miRNA, and shRNA: in vivo Applications Journal of Dental Research, November 1, 2008; 87(11): 992 - 1003. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Nishiuma, Y. Nishimura, T. Okada, E. Kuramoto, Y. Kotani, S. Jahangeer, and S.-i. Nakamura Inhalation of sphingosine kinase inhibitor attenuates airway inflammation in asthmatic mouse model Am J Physiol Lung Cell Mol Physiol, June 1, 2008; 294(6): L1085 - L1093. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W.-Q. Lai, H. H. Goh, Z. Bao, W. S. F. Wong, A. J. Melendez, and B. P. Leung The Role of Sphingosine Kinase in a Murine Model of Allergic Asthma J. Immunol., March 15, 2008; 180(6): 4323 - 4329. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D.-J. Jun, J.-H. Lee, B.-H. Choi, T.-K. Koh, D.-C. Ha, M.-W. Jeong, and K.-T. Kim Sphingosine-1-Phosphate Modulates Both Lipolysis and Leptin Production in Differentiated Rat White Adipocytes Endocrinology, December 1, 2006; 147(12): 5835 - 5844. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Wegmann, B. Petri, A. G. Khandoga, C. Moser, A. Khandoga, S. Volkery, H. Li, I. Nasdala, O. Brandau, R. Fassler, et al. ESAM supports neutrophil extravasation, activation of Rho, and VEGF-induced vascular permeability J. Exp. Med., July 10, 2006; 203(7): 1671 - 1677. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
